NeuroSigma
Curated by SignalDevelops and commercializes trigeminal nerve stimulation (TNS) devices for treatment of psychiatric disorders
Overview
NeuroSigma, Inc. is a medical device company focused on commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD). NeuroSigma is actively engaged in preclinical research and development, as well as groundbreaking Phase I, II, & III clinical trials.
Key facts
- Founded
- 2008
- Headquarters
- Los Angeles, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 1 product or service
- Sign up to view
Contact
- Primary office
- Sign up to view
- Phone
- Sign up to view